Early-stage non-Spitzoid cutaneous melanoma in patients younger than 22 years of age at diagnosis: long-term follow-up and survival analysis.
暂无分享,去创建一个
A. Marghoob | A. Halpern | D. Coit | K. Busam | E. Christison-Lagay | I. Dunkel | Barrie S. Rich | M. L. La Quaglia | Barrie S Rich | Eric J. Stanelle
[1] Alessandro Testori,et al. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis. , 2014, Journal of dermatological science.
[2] N. Hayward,et al. Prognostic value of BRAF mutations in localized cutaneous melanoma. , 2014, Journal of the American Academy of Dermatology.
[3] T. Salopek,et al. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009 , 2014, The British journal of dermatology.
[4] J. Cormier,et al. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States. , 2013, Journal of pediatric surgery.
[5] C. Ingvar,et al. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark’s level of invasion: results of a population‐based study from the Swedish Melanoma Register , 2013, The British journal of dermatology.
[6] R. Scolyer,et al. Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma , 2012, Annals of surgery.
[7] M. Ross,et al. Outcomes in Pediatric Melanoma: Comparing Prepubertal to Adolescent Pediatric Patients , 2011, Annals of surgery.
[8] M. Mihm,et al. AJCC melanoma staging update: impact on dermatopathology practice and patient management , 2011, Journal of cutaneous pathology.
[9] N. Martin,et al. Nevi, family history, and fair skin increase the risk of second primary melanoma. , 2011, The Journal of investigative dermatology.
[10] V. Sondak,et al. Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Messina,et al. Pediatric melanoma: a review. , 2009, Cancer control : journal of the Moffitt Cancer Center.
[12] Jennifer L. Schwartz,et al. The atypical Spitz tumor of uncertain biologic potential , 2009, Cancer.
[13] C. Garbe,et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma , 2008, Cancer.
[14] K. Gow,et al. Melanoma in children and adolescents. , 2007, Surgical oncology.
[15] M. Mihm,et al. Melanoma in the young: Differences and similarities with adult melanoma , 2007, Cancer.
[16] J. Kirkwood,et al. Sentinel Lymph Node Biopsy for Atypical Melanocytic Lesions with Spitzoid Features , 2006, Annals of Surgical Oncology.
[17] S. Ariyan,et al. Gender-Related Differences in Outcome for Melanoma Patients , 2006, Annals of surgery.
[18] T. Fears,et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] A. Marghoob,et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. , 2005, Archives of dermatology.
[20] David Elder,et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Mones,et al. "Atypical" Spitz's nevus, "malignant" Spitz's nevus, and "metastasizing" Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. , 2004, The American Journal of dermatopathology.
[22] A. Alavi,et al. Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas , 2004, Annals of Surgical Oncology.
[23] E. Calonje,et al. Spitz tumors in children: a grading system for risk stratification. , 1999, Archives of dermatology.
[24] K. Busam,et al. Childhood melanoma survival , 1999, Cancer.
[25] T. Flotte,et al. Cutaneous melanoma and atypical spitz tumors in childhood , 1995, Cancer.
[26] M. Peters,et al. Spitz naevi and malignant melanomas of childhood and adolescence , 1986, Histopathology.
[27] R. Mladick. Spindle and epithelioid cell nevi in children and adults, a review of 211 cases of the Spitz nevus , 1978 .
[28] D. Weedon,et al. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the spitz nevus , 1977, Cancer.
[29] F. Dobbelaere,et al. [Spitz's nevus]. , 1973, Archives belges de dermatologie.
[30] S SPITZ,et al. Melanomas of childhood. , 1948, The American journal of pathology.
[31] David E. Elder. Thin melanoma. , 2011, Archives of pathology & laboratory medicine.
[32] D. Jukic. The Atypical Spitz Tumor of Uncertain Biologic Potential: A Series of 67 Patients From a Single Institution , 2010 .
[33] D. Guerry,et al. Mitotic rate as a predictor for sentinel lymph node positivity in patients with thin melanomas , 2006, Annals of Surgical Oncology.
[34] J. Grant-Kels,et al. Continuing medical education : spitz nevi , 1992 .
[35] E. M. Casso,et al. Spitz nevi. , 1992, Journal of the American Academy of Dermatology.